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 High-density lipoprotein (HDL) is one of the fi ve major 
lipoproteins (chylomicrons, VLDL, IDL, LDL, and HDL). 
HDL is the smallest and densest of the lipoproteins be-
cause it contains the highest proportion of protein. A low 
level of HDL cholesterol (HDL-C) is a powerful risk factor 
for cardiovascular disease ( 1–3 ). Accumulating evidence 
suggests, however, that HDL-C alone may not be an ade-
quate marker of atheroprotection. HDLs are composition-
ally and functionally diverse lipoprotein particles, and this 
diversity needs to be taken into account in the evaluation 
of cardiovascular risk ( 4, 5 ). A recent study of HDL pro-
teome revealed many important changes in the protein 
composition of HDL in cardiovascular patients without 
changes in serum HDL-C ( 6 ). 
 Detailed characterization of lipoprotein fractions and 
changes in their molecular lipid profi les may help identify 
novel biomarkers in lipid metabolism ( 7 ). Main lipid con-
stituents of HDL particles include glycerophospholipids, 
cholesteryl esters (ChoE), sphingomyelins (SM), and tri-
acylglycerols (TG). Lysophosphatidylcholines (lysoPC) are 
known to be associated with proatherogenic conditions 
( 8 ). Enrichment of HDL phospholipids, such as phos-
phatidylcholines (PC) and SM, improves the net effl ux of 
 Abstract  A low level of high density lipoprotein cholesterol 
(HDL-C) is a powerful risk factor for cardiovascular dis-
ease. However, despite the reported key role of apolipo-
proteins, specifi cally, apoA-I, in HDL metabolism, lipid 
molecular composition of HDL particles in subjects with 
high and low HDL-C levels is currently unknown. Here lipi-
domics was used to study HDL derived from well-character-
ized high and low HDL-C subjects. Low HDL-C subjects had 
elevated triacylglycerols and diminished lysophosphatidyl-
cholines and sphingomyelins. Using information about the 
lipid composition of HDL particles in these two groups, we 
reconstituted HDL particles in silico by performing large-
scale molecular dynamics simulations. In addition to con-
fi rming the measured change in particle size, we found that 
the changes in lipid composition also induced specifi c spa-
tial distributions of lipids within the HDL particles, includ-
ing a higher amount of triacylglycerols at the surface of 
HDL particles in low HDL-C subjects.   Our fi ndings have 
important implications for understanding HDL metabolism 
and function. For the fi rst time we demonstrate the power 
of combining molecular profi ling of lipoproteins with dy-
namic modeling of lipoprotein structure. —Yetukuri, L., S. 
Söderlund, A. Koivuniemi, T. Seppänen-Laakso, P. S. Niemelä, 
M. Hyvönen, M-R. Taskinen, I. Vattulainen, M. Jauhiainen, 
and M. Orešič. Composition and lipid spatial distribution of 
HDL particles in subjects with low and high HDL-choles-
terol.  J. Lipid Res. 2010.  51:  2341–2351. 
 Supplementary key words high density lipoprotein • lipidomics • 
lipid metabolism • molecular dynamics 
 This work was supported by the European Union-funded project ETHERPATHS 
(FP7-KBBE-222639) (http://www.etherpaths.org/), the Finnish Heart Founda-
tion, the Sigrid Juselius Foundation, and the Helsinki University Central Hos-
pital Research Foundation. 
 Manuscript received 2 March 2010 and in revised form 27 April 2010. 
 Published, JLR Papers in Press, April 27, 2010 
 DOI 10.1194/jlr.M006494 
 Composition and lipid spatial distribution of HDL 
particles in subjects with low and high HDL-cholesterol  
 Laxman  Yetukuri , *  Sanni  Söderlund , †  Artturi  Koivuniemi , §  Tuulikki  Seppänen-Laakso , *  
 Perttu S.  Niemelä , *  Marja  Hyvönen , **  Marja-Riitta  Taskinen , †  Ilpo  Vattulainen , §,††,§§ 
 Matti  Jauhiainen , *** ,††† and  Matej  Orešič 1, * ,††† 
 VTT Technical Research Centre of Finland ,* Espoo,  Finland , Division of Cardiology, † Department of 
Medicine,  University of Helsinki , Helsinki,  Finland , Department of Physics, §  Tampere University of 
Technology , Tampere,  Finland , Department of Physics,**  University of Oulu ,  Finland , Department of 
Physics, ††  Aalto University School of Science and Engineering , Espoo,  Finland , MEMPHYS – Center for 
Biomembrane Physics, §§  University of Southern Denmark , Odense,  Denmark ,  National Institute for Health 
and Welfare ,*** Helsinki,  Finland ,  Institute for Molecular Medicine Finland (FIMM) , ††† Helsinki,  Finland 
 Abbreviations: Apo, apolipoprotein;  CETP, cholesteryl ester trans-
fer protein; ChoE, cholesteryl ester; CRP, C-reactive protein; FCho, 
free cholesterol; FDR, false discovery rate ; HDL-C, high-density lipo-
protein cholesterol; IL, interleukin; LDL-C, low-density lipoprotein 
cholesterol; lysoPC, lysophosphatidylcholine; MS, mass spectrometry; 
PC, phosphatidylcholine; PE, phosphatidylethanolamine; PLS/DA, 
partial least square discriminant analysis; PLTP, phospholipid transfer 
protein; RCT, reverse cholesterol transport; SM, sphingomyelin; TG, 
triacylglycerol; TNF, tumor necrosis factor; UPLC, ultra performance 
liquid chromatography. 
 1 To whom correspondence should be addressed.  
  e-mail: matej.oresic@vtt.fi  
  The online version of this article (available at http://www.jlr.org) 
contains supplementary data in the form of three tables and ten fi g-
ures. 
 at Terkko - N
ational Library of Health Sciences, on M
ay 16, 2016
w
w
w
.jlr.org
D
ow
nloaded from
 
.html 
http://www.jlr.org/content/suppl/2010/04/29/jlr.M006494.DC1
Supplemental Material can be found at:
2342 Journal of Lipid Research Volume 51, 2010
using systemic estrogen, corticosteroid therapy, statins, or other 
drugs affecting HDL metabolism were excluded. Each study sub-
ject gave a written informed consent before participating in the 
study. The samples were collected in accordance with the Hel-
sinki declaration, and the ethics committees of the participating 
centers approved the study design.  Table 1 presents the charac-
teristics of the low and high HDL-C subjects. 
 Lipoprotein separation and characterization 
 HDL for the lipidomic analysis was separated from plasma 
samples by ultracentrifugation ( 20 ). HDL subspecies distribution 
and HDL mean particle size were determined with native gradi-
ent gel electrophoresis ( 21 ) with minor modifi cations as previ-
ously described ( 11 ). The molecular size intervals for HDL 
subspecies 2b, 2a, 3a, 3b, and 3c were used according to Blanche 
et al. ( 21 ), and for each subspecies, the relative area under the 
densitometric scan were reported. HDL mean particle size was 
calculated by multiplying the mean size of each HDL subclass by 
its relative area under the densitometric scan ( 22 ). LDL peak 
particle size was measured with gradient gel electrophoresis as 
previously described in detail ( 23 ). 
 Biochemical analyses 
 Venous blood samples were drawn after an overnight fast. Se-
rum and EDTA plasma samples were stored at   70°C before 
analysis. Serum total cholesterol (TC), TG, and HDL-C were 
measured with Olympus AU400 clinical chemistry analyzer 
(Olympus, Hamburg, Germany) by fully enzymatic methods 
(Olympus kits OSR 6116 and 6133 for TC and TG, respectively, 
and Roche Diagnostics kit 3030024 for HDL-C) (Roche Diagnos-
tics GmbH, Mannheim, Germany). LDL-C was calculated using 
the Friedewald formula ( 24 ). Concentrations of apoA-I and apo-
lipoprotein B (apoB) were measured with Olympus AU400 ana-
lyzer by immunoturbidometric methods (kits 64265 and 67249 
from Orion Diagnostica, Espoo, Finland). Serum apolipoprotein 
A-II (apoA-II) was measured with Cobas Mira analyzer (Hoffman-La 
Roche, Basel, Switzerland) immunoturbidometrically (Wako 
Chemicals GmbH, Neuss, Germany, and own polyclonal antibody 
produced in rabbits against purifi ed human apoA-II). Serum 
apoE concentration was quantitated by ELISA ( 25 ). Plasma glu-
cose was measured by the glucose dehydrogenase method (Merck 
Diagnostica, Darmstadt, Germany). Plasma insulin was measured 
by radioimmunoassay (Pharmacia AB, Uppsala, Sweden). 
 Phospholipid transfer protein (PLTP) activity was measured 
using the radiometric assay as previously described ( 26 ) with mi-
nor modifi cations ( 27 ). PLTP concentration was measured with 
ELISA ( 28 ). Cholesterol ester transfer protein (CETP) activity 
was measured with radiometric assay as described by Groener 
et al. ( 29 ). Paraoxonase activity was measured with spectropho-
tometry ( 30 ). Nitrotyrosine concentration was measured with 
ELISA using kit HK 501 (HyCult Biotechnology, Uden, The 
Netherlands). The measurements of interleukin-6 (IL-6), tumor 
necrosis factor-  (TNF-  ), and C-reactive protein (CRP) were 
done using the immuno-chemiluminometric assay (Immulite, 
DPC, Siemens Healthcare Diagnostics, USA). 
 Blood pressure values are the mean values from three consec-
utive measurements carried out in 1–2 min intervals. Data on al-
cohol consumption was collected from questionnaires fi lled in by 
the study subjects. 
 Lipidomic analysis 
 An internal standard mixture containing 10 lipid compounds 
was added to each sample (20 µl of total HDL fraction). Lipids 
were extracted with chloroform/methanol (2:1, v/v, 100 µl) sol-
vent. The samples were centrifuged (10000 rpm, 3 min), 60 µl of 
the lower lipid extract was taken into an HPLC vial insert, and 
cholesterol from scavenger receptor-BI expressing cells 
( 9 ), and phospholipid composition may have a major im-
pact in the process of reverse cholesterol transport (RCT) 
( 10 ). We also demonstrated using HDL derived either 
from low or high HDL-C subjects that cholesterol effl ux 
from human THP-1 macrophages correlated with phos-
pholipids, particle size, and particle mass of HDL ( 11 ). 
This is consistent with earlier effl ux studies demonstrating 
that the phospholipid content of HDL is an important de-
terminant of cholesterol egress ( 12, 13 ). Additionally, the 
activity of HDL in the fi rst step of RCT is affected by the 
fatty acyl chain length of the phospholipids ( 14 ). To-
gether, the information on lipid molecular composition of 
HDL may provide better insights into the mechanisms be-
hind the anti-atherogenic role of HDL particles. 
 Conventional lipoprotein analyses have relied on analy-
ses of total protein, phospholipid, free cholesterol, ChoE, 
and TG content ( 15 ). However, molecular level concentra-
tions may provide more precise markers of specifi c meta-
bolic phenotypes than total lipid class concentrations ( 16 ). 
Recent advances in mass spectrometry (MS)-based analyti-
cal platforms and bioinformatic approaches for managing 
large volumes of data have made it possible to study lipid 
species at the molecular level ( 17, 18 ). The lipidomics plat-
form based on ultra performance liquid chromatography 
mass spectrometry (UPLC/MS) was recently utilized to 
characterize molecular lipids, including triacylglycerols, 
glycerophospholipids, sphingomyelins, cholesteryl esters, 
and ceramides in different lipoprotein fractions ( 16 ). 
 Lipid molecular composition of HDL particles in sub-
jects with high and low HDL-cholesterol levels has not 
been studied systematically. Here we combine clinical 
cohort study and global lipidomics with molecular simu-
lations of HDL particles. We apply UPLC/MS-based lipi-
domics to study HDL fractions from well-characterized 
high and low HDL-C subjects from a large Finnish popula-
tion cohort, and we identify many specifi c changes in HDL 
lipidomes among subjects with high and low HDL-C. Us-
ing information about the lipid composition of HDL par-
ticles in these two groups, we reconstitute HDL particles in 
silico by performing large-scale molecular dynamics simu-
lations. In addition to confi rming the measured change in 
particle size, we show that HDL particles derived from 
high HDL-C subjects have a surprisingly different spatial 
distribution of triacylglycerols. 
 MATERIALS AND METHODS 
 Study subjects 
 The study comprised 47 subjects: 24 low HDL subjects and 23 
high HDL subjects who were participants in the Health 2000 
Health Examination Survey ( 19 ). The subjects represented the 
extreme ends of HDL-C levels (  10th percentile and   90th per-
centile). HDL-C limits were as follows: low HDL-C men   1.03 
mmol/l, low HDL-C women   1.23 mmol/l, high HDL-C men   
1.79 mmol/l, and high HDL-C women   2.24 mmol/l. Subjects 
with diabetes, alcohol abuse, or malignancy were excluded. Alco-
hol abuse was defi ned as >160 g of alcohol per week for women 
and >310 g of alcohol per week for men. In addition, subjects 
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scores were used to optimize the models. The variable impor-
tance in the projection (VIP) values ( 34 ) were computed to iden-
tify most important lipid species contributing to separation of 
low and high HDL-C groups in the PLS/DA model. PLS/DA 
model was built using Matlab, version 7.0 (Mathworks, Natick, 
MA) and PLS Toolbox, version 4.0, of the Matlab package (Eigen-
vector Research, Wenatchee, WA). 
 Construction of simulation systems and simulation 
parameters 
 In the case of apoA-I, we fi rst built an all-atom model for 
apoA-I based on the previous data, and then we coarse grained 
the structure. The relative conformation of apoA-Is was similar to 
the belt-like structure of Borhani et al. who produced the solu-
tion X-ray structure of truncated apoA-I (residues 44-243) ( 35 ). 
We also followed the approach of Segrest et al. who arranged ato-
mistic apoA-Is around the lipid moiety in belt-like fashion ( 36 ) so 
that the hydrophobic sides of amphiphilic   -helices were point-
ing toward the lipid moiety. This structure was further used to 
build a model for the full-length apoA-I by adding the previously 
absent N-terminal part (residues 1-43) of the apoA-I to our 
model. The conformation of this segment was determined to be 
  -helical as suggested by the previous NMR data ( 37 ). The hydro-
phobic side of this helix was also orientated toward the lipid moi-
ety. We directly coarse grained the atomistic structure and placed 
the apoA-Is around the previously simulated lipid droplet. The 
secondary structure of apoA-I was enforced almost completely to 
the   -helical conformation; only the N- and C-terminal ends were 
modeled as random coils. This approach has been used previ-
ously in the work of Catte et al. with truncated apoA-I ( 38 ). Thus, 
the fl exibility of   -helical segments arises from the three-body 
angle and four-body dihedral potentials of backbone beads that 
were produced by Monticelli et al. to extend the MARTINI force 
fi eld to proteins ( 39 ). The radius of the ring formed by apoA-Is 
was   12.5 nm, and the average distance between apoA-Is was 
2.5–3.0 nm. 
 Next, to produce starting structures for the low HDL-C, nor-
mal HDL-C, and high HDL-C systems, the lipid composition of 
another standard mixture containing three labeled lipid com-
pounds was added. The internal standards include PC(17:0/
0:0), PC (17:0/17:0), PE(17:0/17:0), PG(17:0/17:0)[rac], 
Cer(d18:1/17:0), PS(17:0/17:0), PA(17:0/17:0) and D- erythro -
Sphingosine-1-Phosphate (C17 Base) from Avanti Polar Lipids 
(Alabaster, AL) and MG(17:0/0:0/0:0)[rac], DG(17:0/17:0/0:0)
[rac], and TG(17:0/17:0/17:0) from Larodan Fine Chemicals 
(Malmö, Sweden). The labeled standards include PC(16:0/0:0-
D3), PC(16:0/16:0-D6), and TG(16:0/16:0/16:0- 13 C3 from Laro-
dan Fine Chemicals. 
 Lipid extracts (2 µl injections) were analyzed on a Waters 
Q-Tof Premier mass spectrometer combined with an Acquity 
Ultra Performance LC™ (UPLC™) (Waters Inc., Milford, MA). 
The column was an Acquity UPLC BEH C18 10 × 50 mm with 1.7 
µm particles and the gradient solvent system included water 
(1% 1M NH 4 Ac, 0.1% HCOOH) and LC/MS grade (Rathburn) 
acetonitrile/isopropanol (5:2, 1% 1M NH 4 Ac, 0.1% HCOOH). 
The total run time, including a 5 min reequilibration step, was 
18 min. The fl ow rate was 0.200 ml/min. The data were collected 
at mass range of  m/z 300–1200 with a scan duration of 0.2 s in 
ESI+ mode. 
 Statistical methods 
 Statistical analyses were performed using a freely available 
R language (http://www.r-project.org/). False discovery rate 
(FDR)  q -values were computed using statistical methods from R 
package “qvalue.” Correlation analysis was performed using 
“gplots” library from R package. 
 Chemometric modeling of data 
 Supervised model was built for clustering and discrimination 
using partial least squares discriminant analysis (PLS/DA) ( 31, 
32 ). The PLS/DA model attempts to get the latent variables by 
maximizing the covariance between measured data (X) (e.g., 
lipid profi le data) and response variables of interest (Y) (e.g., 
high HDL-C and low HDL-C groups). The model was built by 
scaling X data to unit variance and zero mean, and Y data to zero 
mean. The random subsets cross validation method ( 33 ) and Q 2 
 TABLE 1. Clinical and biochemical characteristics of the study subjects 
Low HDL Subjects
(Median IQR)
High HDL Subjects
(Median IQR)  P a 
N (men/women) b 24 (12/12) 23 (12/11)
Age (years) 53 (51–56) 54 (50–60) 0.564
Body mass index (kg/m 2 ) 27.9 (24.3–31.5) 22.8 (21.4–24.6) <0.001
Systolic blood pressure (mmHg) 131 (118–146) 132 (121–147) 0.647
Diastolic blood pressure (mmHg) 81 (75–89) 81 (75–87) 0.882
Total cholesterol (mmol/l) 5.15 (4.55–5.60) 5.80 (5.30–6.10) <0.001
HDL cholesterol (mmol/l) 0.94 (0.86–1.10) 2.52 (2.12–2.61) <0.001
LDL cholesterol (mmol/l) 3.30 (2.87–3.67) 3.01 (2.68–3.55) 0.225
Insulin (mU/l) 9.15 (7.05–10.93) 6.00 (5.00–7.90) 0.0015
Triglycerides (mmol/l) 1.80 (1.23–2.25) 0.70 (0.60–0.90) <0.001
apoA-I (mg/dl) 134 (121–144) 222 (206–234) <0.001
apoA-II (mg/dl) 28.0 (27.0–34.5) 39.0 (35.0–45.0) <0.001
apoB (mg/dl) 124.5 (106.3–135.0) 99.0 (84.0–109.0) <0.001
PLTP activity (nmol/ml/h) 4765 (4109–5549) 5304 (4798–5810) 0.058
PLTP mass (µg/ml) 7.5 (6.4–9.2) 8.6 (6.8–9.5) 0.328
CETP activity (nmol/ml/h) 28 (25–33) 31 (27–38) 0.250
TNF-  (ng/l) 6.5 (4.5–8.2) 4.7 (4.1–5.8) 0.038
IL-6 (ng/l) 1.6 (1.0–2.1) 1.1 (0.8–2.0) 0.163
hs-CRP (mg/l) 1.4 (0.8–2.7) 0.7 (0.4–1.2) 0.012
HDL size (nm) 9.0 (8.8–9.2) 9.9 (9.7–10.2) <0.001
Abbreviations: Apo, apolipoprotein; CETP, cholesteryl ester transfer protein; hs-CRP, high sensitivity C-reactive 
protein; IL, interleukin; IQR, interquartile range; PLTP, phospholipid transfer protein; TNF, tumor necrosis 
factor.
 a P -value from Mann-Whitney  U test.
 b  apoA-II measurements of three subjects in both low and high HDL-C groups are not available; hence, 
calculations are based on measurements from the remaining subjects.
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mass index ( P < 0.001), lower triglyceride ( P < 0.001) and 
insulin ( P = 0.0015), as well as lower TNF-  ( P = 0.038) and 
hs-CRP ( P = 0.012) levels in plasma. The two groups had 
similar PLTP mass and CETP activity levels ( Table 1 ). As 
expected, high HDL-C subjects had higher apoA-I ( P < 
0.001) and lower apoB ( P < 0.001) values than low HDL-C 
subjects. 
 Lipidomic profi ling of HDL fractions 
 To characterize the HDL-associated lipids at the molec-
ular level, the established lipidomics platform using 
UPLC/MS was applied as described previously ( 43 ). A to-
tal of 307 molecular lipids across 12 functional classes 
were detected. PLS/DA revealed that the HDL lipidomic 
profi les in low HDL-C and high HDL-C subjects are clearly 
different ( Fig. 1A ). As shown by clustering of the top-
ranked discriminant lipids in  Fig. 1B , the HDL composi-
tional changes in high HDL-C subjects compared with low 
HDL-C subjects were dominated by elevated lysoPCs, SMs, 
and ChoEs, and diminished TGs. No within-class trend 
was observed between the low and high HDL-C groups for 
PCs. Box plots for the most abundant lipids from lysoPC, 
SM, ChoE, ethanolamine plasmalogen (PEp) and TG 
classes are shown in  Fig. 2 . The most signifi cant identifi ed 
lipid species with their fold changes and FDR  q- values are 
shown in supplemental Table I. Full lipidomics results for 
307 detected lipid peaks are shown in supplemental Table 
II. The observed, highly signifi cant differences between 
the HDL lipidomic profi les of the high and low HDL-C 
groups were not attributed to gender (supplemental Fig. 
I) or TG fatty acid composition (supplemental Fig. II), 
despite the observed gender differences in HDL subspe-
cies distribution in the low HDL-C group (supplemental 
Table III). 
 Although not among the most abundant HDL phospho-
lipids, several of the ether lipids were found among the 
most signifi cantly different in high and low HDL groups 
( Fig. 1 and supplemental Table II), including the etha-
nolamine plasmalogens PE(P-16:0/18:2), PE(P-16:0/20:4), 
and PE(P-18:1/20:4) (supplemental Table II). The etha-
nolamine plasmalogens as well as PC ether lipids contain-
ing high number of double bonds were diminished in the 
high HDL group, while the more saturated ether PCs were 
the previously simulated lipid droplet was tuned according to 
 Table 2 . All lipid molecules, except those that were added to the 
starting system, were inside the ring formed by apoA-Is. Next all 
three systems were energy minimized by the steepest descent al-
gorithm, and 10 ns vacuum simulations were carried out to get 
lipids to the one unifi ed phase, which meant that the added lip-
ids diffused to the main lipid particle. Systems were solvated, and 
18 water beads were changed to Na + beads to neutralize the 
charges in the systems. Production simulations lasted for 2   s, 
which corresponds to 8   s of effective time as the MARTINI 
model speeds up the dynamics by an approximate factor of four 
( 39 ). System sizes were approximately 30,000–35,000 water beads 
and 4,300–5,000 lipid and protein beads in total. The box size in 
each simulation was 17 × 17 × 17 nm. 
 Simulations were performed by the GROMACS simulation 
package (v. 4.0) ( 40 ). The standard MARTINI lipid force fi eld 
was used for PC (PC(16:0/18:1)), lysoPC (PC(16:0/0:0)), FCho, 
and SM (SM(d18:1/16:0)) molecules ( 41 ). Protein part was mod-
eled using the protein extension of the MARTINI description 
( 39 ). TG (TG(18:1/18:1/18:1)) and ChoE (ChoE(18:1)) force 
fi elds were constructed based on the philosophy of MARTINI 
force fi eld (the exact parameters and validation are available 
elsewhere ( 38 )). In all simulations, temperature was set to 310 K 
and pressure to 1 bar. Berendsen temperature and pressure cou-
pling algorithms ( 42 ) were utilized with coupling constants of 0.4 
ps and 2.0 ps, respectively. All lipid classes, apoA-Is, water, and 
ions were separately coupled to heat bath. Electrostatic and Len-
nard-Jones interactions were calculated using the shift type po-
tentials with cut-off lengths of 1.2 nm, and the potentials were 
shifted to zero starting at 0.0 and 0.9 nm, respectively. Time step 
was set to 0.025 ps. In each case, the fi rst 4   s were treated as 
equilibration simulation; the last 4   s were used in the analysis. 
GROMACS analysis programs g_rdf, g_mindist, g_gyrate, and 
g_rmsf were used in the analysis. 
 RESULTS 
 Characteristics of the study subjects 
 Clinical and biochemical characteristics of low and high 
HDL-C subjects are shown in  Table 1 . As expected, the 
high HDL-C subjects had higher fasting serum HDL-C 
( P < 0.001) and total cholesterol ( P < 0.001) concentra-
tions compared with low HDL-C subjects. However, fasting 
serum LDL-C concentrations between the groups did not 
differ signifi cantly. High HDL-C subjects were leaner com-
pared with low HDL-C subjects, and they had lower body 
 TABLE 2. Lipid compositions and concentrations used in simulations 
Lipid Compositions a Determined by Lipidomics
apoA-I SM PC FCho ChoE TG lysoPC
Normal HDL-C 2 18 109 50 90 19 10
Low HDL-C 2 13 109 25 81 24 5
High HDL-C 2 23 109 75 99 14 15
Average Concentrations b of Lipid Classes Determined by Lipidomics
SM HDL-C ChoE TG lysoPC
Low HDL-C 0.057 ± 0.003 7.545 ± 0.200 0.105 ± 0.009 0.436 ± 0.024 0.014 ± 0.007
High HDL-C 0.082 ± 0.004 10.928 ± 0.254 0.132 ± 0.020 0.244 ± 0.036 0.022 ± 0.002
Abbreviations: Apo, apolipoprotein; ChoE, cholesteryl ester; FCho, free cholesterol; HDL-C, high-density 
lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; lysoPC, lysophosphatidylcholine; SM, 
sphingomyelin; TG, triacylglycerol.
 a  Number of molecules per HDL particle.
 b  Units are   mol/l [lipid] / mg/dl [apoA-I].
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was a negative correlation in high HDL-C subjects ( r = 
-0.43,  P = 0.04). No signifi cant correlations were found be-
tween ChoE(18:1) and HDL-C, in either low HDL-C sub-
jects ( r = 0.33,  P = 0.12) or high HDL-C subjects ( r = 0.02, 
 P = 0.92). Correlation analysis was also performed for the 
HDL particle size versus the selected lipids (supplemental 
Figs. IV and V). HDL particle size correlated positively 
with lysoPC(18:0) ( r = 0.50,  P = 0.0003) and SM(d18:1/16:0) 
( r = 0.58,  P = 0.0003), and negatively with TG(16:0/18.1/
20:1) ( r =   0.51,  P < 0.0001). No such signifi cant correla-
tions were observed when analyzing the low and high 
HDL-C groups separately. 
 Simulations of HDL particles 
 Our fi ndings imply that the lipid composition of HDL 
particles derived from subjects with high and low HDL cho-
lesterol is very different. To gain further insight how the 
elevated compared with the levels in the low HDL group. 
The top-ranked lipids derived from PLS/DA ( Fig. 1A ) 
were correlated with the selected clinical variables (sup-
plemental Fig. III). TG concentrations were negatively 
correlated while SM and lysoPC concentrations were posi-
tively correlated with the HDL-C concentration. 
 We then investigated association of HDL-C with the top-
ranked lipids from different lipid classes in low and high 
HDL-C subjects separately (supplemental Figs. IV and V). 
Positive correlations between SM(d18:1/16:0) and HDL-C 
were similar in low HDL-C subjects ( r = 0.71,  P = 0.0001) 
and high HDL-C subjects ( r = 0.71,  P = 0.0001). Interest-
ingly, positive correlation identifi ed between lysoPC(18:0) 
and HDL-C in low HDL-C subjects ( r = 0.54,  P = 0.006) was 
absent in the high HDL-C group ( r = -0.06,  P = 0.78). We 
observed no correlation of TG(16:0/18:1/20:1) with HDL-
C in low HDL-C subjects ( r = 0.06,  P = 0.75), whereas there 
 Fig.  1. A: Partial least squares discriminant analy-
sis (PLS/DA) of lipidomic profi les for low HDL-C 
and high HDL-C subjects. PLS/DA scores plot with 
two different HDL-C groups are marked. Two latent 
variables were used (Q 2 = 51%). B: Hierarchical 
clustering on most important variable importance 
in the projection (VIP) variables and samples in the 
heat map refl ecting fold changes of lipids relative to 
mean intensity within the low HDL-C group. Bars 
show fold changes refl ecting mean intensity of top 
VIP variables in the high HDL-C group relative to 
mean intensity within the low HDL-C group.  at Terkko - N
ational Library of Health Sciences, on M
ay 16, 2016
w
w
w
.jlr.org
D
ow
nloaded from
 
.html 
http://www.jlr.org/content/suppl/2010/04/29/jlr.M006494.DC1
Supplemental Material can be found at:
2346 Journal of Lipid Research Volume 51, 2010
the simulation (supplemental Fig. VI). To estimate the hy-
drodynamic particle radii (R H ), we used the relation (R g = 
sqrt(3/5) R H ) for a uniform sphere. The hydrodynamic 
diameter of the high HDL-C particle was estimated to be 
9.7 nm, and of the low HDL-C, 9.4 nm. As an indirect vali-
dation of our combined experimental and modeling 
strategy, the diameters calculated from simulations are in 
approximate agreement with our hydrodynamic particle 
diameters produced by electrophoresis, with the respec-
tive diameters of 9.9 and 9.0 nm when comparing high 
and low HDL-C particle profi les. One should note that 
the experimental size measurements include all HDL 
fractions, and thus, it is not directly comparable with our 
simulations. However, the results are within the right size 
range. 
 Interestingly, we registered by visual inspection that free 
cholesterol (FCho) molecules accumulated next to apoA-I 
proteins, indicating that free cholesterol molecules inter-
act more favorably with apoA-I ( Fig. 3B ). This interaction 
may have important implications for the HDL metabolism 
as the cholesterol molecule concentration in the particles 
can modulate the conformational fl uctuations of apoA-I 
or even change it. Indeed, studies with human apoA-I have 
shown that cholesterol decreases the adsorption of the 
apolipoprotein to a phospholipid monolayer, and the con-
formation of apoA-I varies from one lipid monolayer to 
another, implying similar effects on the surface of HDL 
particles ( 45 ). It has been suggested that LCAT activity de-
pends on the conformation of apoA-I ( 46, 47 ); thus, the 
cholesterol concentration could also be linked to the 
activation of LCAT and other HDL-associated proteins. 
Therefore, we calculated the number of contacts between 
changes in the lipid composition of HDL may infl uence 
HDL structure and function, we performed coarse-grained 
simulations of HDL particles, with their molecular composi-
tion derived from within-group mean selected lipid con-
centrations obtained by lipidomics. Three coarse-grained 
molecular dynamic simulations with different lipid compo-
sitions were carried out. In addition to “high HDL-C” and 
“low HDL-C” particles, we simulated “normal HDL-C” as an 
intermediate between the two. The number of lipids used 
in each simulation is listed in  Table 2 . The lipid species con-
centrations obtained in global lipidomic profi ling were ex-
pressed relative to the moles of apoA-I content. If lipid 
species in a certain class were contributing to separation of 
low and high HDL-C groups per the PLS/DA model, the 
averaged concentration of all species in that class was used 
to fi nd the estimate of fold changes between low and high 
HDL-C groups. Alternatively, for the lipid species such as 
cholesteryl esters, which did not contribute much in the 
separation of the two HDL-C groups as per the model, the 
averaged concentration levels of all identifi ed species were 
used to fi nd the fold change estimate between the low and 
high HDL-C groups. Thus, obtained fold change values be-
tween low and high HDL-C groups were used to estimate 
the number of species per HDL particle in low and high 
HDL-C particles by comparing the numbers in the normal 
HDL-C compositions. The lipid composition for the nor-
mal-HDL model was chosen based on the previous article 
( 44 ) that describes the detailed molecular composition of 
the HDL2-subfraction. 
 The size of simulated HDL particles decreased when 
moving from high to low HDL-C particles. This can be 
clearly seen from the radii of gyration (R g ) obtained from 
 Fig.  2. Box plots of the most abundant lipids within the TG, lysoPC, SM, ChoE, and ethanolamine plas-
malogen (PEp) classes. Concentrations are shown in   mol/l [lipid] / mg/dl [apoA-I]. High, high HDL-C; 
Low, low HDL-C. ChoE, cholesteryl ester; lysoPC, lysophosphatidylcholine; SM, sphingomyelin; TG, 
triacylglycerol. 
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TGs and water phase, divided by the number of TG mole-
cules ( Fig. 3C ). The relative solubility of TG increased with 
fewer surface lipids in the HDL particles. 
 DISCUSSION 
 Our study revealed marked differences in HDL lipi-
domic profi les as well as related clinical and biochemical 
characteristics between low and high HDL-C subjects. For 
the fi rst time, the molecular profi ling of HDL (or other 
lipoprotein) particles was combined with dynamic struc-
tural modeling. Such an approach allowed us to show that 
the lipid compositional changes also induce specifi c spa-
tial distributions of lipids within the HDL particles. 
 The composition of lipid and apolipoprotein compo-
nents is critical in maintaining normal HDL metabolism as 
well as function. The HDL biosynthesis is very complex 
and associated with major steric and lipid interaction 
changes in structural apolipoproteins, such as apoA-I and 
apoA-II. ApoA-I, which constitutes about 70% of HDL pro-
tein content, is present in almost all HDL particles ( 48 ). 
The lack of the apoA-I gene is associated with low HDL-C 
levels in mice ( 49 ) and humans ( 50 ). This association is 
valid with our observations, with the low HDL-C subjects 
displaying lower levels of apoA-I as well as apoA-II, which 
constitutes approximately 20% of HDL protein ( 51 ). 
different lipid species and apoA-I ( Fig. 3B ). Furthermore, 
we produced root mean square fl uctuation (RMSF) curves 
for apoA-I in different cases to characterize differences in 
the local fl uctuations (supplemental Fig. VII). The num-
ber of contacts increased between pairs SM-apoA-I, FCho-
apoA-I, and lysoPC-apoA-I when moving from low HDL-C 
to high HDL-C ( Fig. 3B ). In contrast, the number of con-
tacts decreased between pairs ChoE-apoA-I, TG-apo-A-I, 
and PC-apoA-I. However, only the cholesterol molecules 
accumulate preferably next to apoA-I proteins indepen-
dent of cholesterol concentration. This suggests that ei-
ther the partitioning of cholesterol in HDL particles is 
entropy-driven or apoA-I possess high cholesterol affi nity. 
 To study how the changes of lipid composition may af-
fect the spatial distribution of specifi c lipid classes in HDL 
particles, we calculated the 3D radial distribution func-
tions (RDF) for different lipid components with respect to 
the center of mass of HDL particles ( Fig. 3C and supple-
mental Figs. VIII-X). Most notably, in low HDL-C the RDF 
of triacylglycerols indicated stronger prevalence of TG 
molecules at the surface ( Fig. 3C ) when the amount of 
cholesterol as well as other surface lipids decreases. The 
prevalence of cholesteryl esters did not change accord-
ingly (supplemental Figs. VIII-X). Furthermore, we esti-
mated the relative solubility TGs to the surface lipid 
monolayer by calculating the number of contacts between 
 Fig.  3. Coarse-grained simulations of HDL particles reconstituted based on lipidomics data. A: Snapshots from the end of high and low 
HDL-C simulations (8   s). Apo-AIs are colored with red and green, cholesterol molecules are yellow, and all other lipids are gray. Water 
phase was removed from the snapshots for clarity. Middle snapshot demonstrates how the cholesterol molecules are localized next to and 
under apoA-Is in high HDL-C simulation. B: The number of contacts between apoA-Is and different lipid beads in each simulation (error 
bars indicate ± SD). The number of contacts was not normalized with the number of different lipid constituents. C: Radial distribution 
function for TG molecules g(r) with respect to the center of mass (COM) of HDL particle. When surface lipid concentration decreases, 
more TGs are able to penetrate the surface monolayer, which is seen as a formation of higher plateaus near 3.5 nm. The number of contacts 
between TG and water beads (per TG) in different simulations is shown in the inset. Apo, apolipoprotein; TG, triacylglycerol. 
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position of the HDL particles. Interestingly, sphingomy-
elin content of HDL particles has been reported to affect 
LCAT activity ( 66, 67 ). 
 Intriguingly, as the conformation of apoA-I is different 
in each simulation performed in the present study, the no-
table differences in the fl uctuations of apoA-I are possibly 
infl uenced by the conformation of the protein around the 
particle. As mentioned above, the conformation of apoA-I 
could depend on the size and lipid composition of the par-
ticles; in particular, the concentration of free cholesterol 
could be a critical determinant of apoA-I conformation as 
it was noticed by the simulations that cholesterol mole-
cules favorably interact with apoA-I. Presumably, the con-
formation and dynamical properties of apoA-I around the 
HDL particles are constantly changing as the lipid and 
protein moieties vary. Therefore, producing any static or 
unifi ed conformational data for apoA-Is around the native 
HDL particles is very challenging. However, by means of 
state-of-the-art coarse-grained simulations we can now sta-
tistically defi ne the most probable conformations of apoA-
Is induced by the different molecular compositions of 
HDL particles. However, note that we should carry out 
more simulations to give more statistical power to the con-
formational changes seen in the present simulations. Our 
main aim in this study was to include an apoA-I model that 
covers same surface area as native apoA-I in the HDL par-
ticles and that is able to play a role in lipid partitioning. 
For this reason, the protein tertiary structural differences 
seen in our simulation must be treated with certain cau-
tion. Notably, the fatty acyl chain saturation/desaturation 
degree of phospholipids may affect the lateral movement 
of apoA-I on the particle surface. 
 Levels of polyunsaturated fatty acid containing ether 
phospholipids, including ethanolamine plasmalogens, 
were elevated in the HDL fractions of subjects with low 
HDL-C. Not much is known about the PC ether lipids in 
HDL, and in contrast to PE ether lipids ( 68 ), unambigu-
ous structural characterization of these lipids is at present 
not possible. PE plasmalogens are known to be more abun-
dant in HDL compared with other lipoprotein fractions 
( 7 ). Plasmalogens can serve as antioxidants against reac-
tive oxygen species (ROS) and may prevent the oxidation 
of cholesterol ( 69 ). However, under oxidative stress, the 
arachidonic acid-containing plasmalogens, such as found 
in our study, become precursors of potent infl ammatory 
mediators, such as leukotrienes and hydroxyeicosatetra-
enoic acids ( 70 ). Together, the role of ether lipids in 
HDL function is likely complex and demands further 
investigation. 
 Sphingomyelin subspecies with different fatty acyl struc-
tures were higher in high HDL-C subjects. Interestingly, 
we also demonstrated that high HDL-C subjects have lower 
plasma TNF  as well as hs-CRP levels compared with those 
of low HDL-C subjects. This observation has important 
consequences when connected to sphingomyelin metabo-
lism. A key event in atherogenesis is endothelial activation 
induced by a variety of stimuli, such as TNF-  , resulting in 
the expression of various adhesion proteins ( 71 ). The ex-
pression of adhesion proteins on activated endothelial 
 The combined information from the key metabolic reg-
ulators and lipid profi les may provide the basis for mecha-
nistic links in HDL metabolism. In addition to apoA-I and 
apoA-II, the key metabolic regulators, such as CETP, leci-
thin-cholesterol acyltransferase (LCAT), endothelial li-
pase (EL), hepatic lipase (HL), and PLTP, play a central 
role in continuous intravascular remodeling of HDL par-
ticles. ApoA-I acts as a cofactor for LCAT, the enzyme re-
sponsible for transforming the free cholesterol to 
cholesteryl ester in the core of HDL ( 52 ). As higher apoA-I 
levels closely associated with high HDL-C ( 48, 53 ), higher 
HDL-cholesteryl ester content was observed in high HDL-
C subjects compared with low HDL-C groups ( Fig. 2D ). 
The cholesteryl esters in HDL are continuously exchanged 
for TG in very low-density lipoprotein (VLDL) or chylomi-
crons in a process mediated by CETP activity. Our fi ndings 
revealed increases of TG content in HDL particles in low 
HDL-C subjects, thus favoring the active ChoE/TG ex-
change process. TG enrichment of HDL notably increases 
the ability of hepatic lipase to remodel these HDL particles 
( 54, 55 ), resulting in release of lipid-poor apoA-I and en-
hanced clearance of HDL via the kidneys. It is known that 
cubilin acts as a receptor for the endocytosis of apoA-I in 
the kidney ( 56, 57 ). 
 Previous data suggest that in HDL particles the percent-
age of ChoEs of all surface lipids is 13–27% due to high 
tendency of ChoEs to locate on the surface and high con-
centration of ChoEs in these particles ( 58 ). Thus the 
known heteroexchange of ChoEs and TGs between HDL 
particles and apoB-100-containing lipoproteins is rational 
only if the acceptor and donor surfaces have different mo-
lar proportions of ChoE and TG ( 58 ). In addition, higher 
concentration of TG molecules at the surface of HDL par-
ticles could give a better chance for hepatic lipase to mod-
ify them. 
 The phospholipid content in HDL is regulated by PLTP, 
another important factor ( 59 ). Mice with mild overexpres-
sion of PLTP did not reveal signifi cant changes in HDL, 
but those lacking PLTP have low HDL-C levels ( 60, 61 ). 
On the other hand, strong induction of PLTP expression 
strongly lowered total plasma HDL levels in a dose-depen-
dent way because of accelerated fractional catabolism of 
HDL ( 62 ). In the present study, PLTP activities did not 
differ between the two HDL groups, suggesting that PLTP 
cannot be responsible for the low HDL levels. PLTP facili-
tates the transfer of phospholipids between lipoprotein 
particles and regulates both size and composition of HDL 
particles. The TG content of HDL has a major infl uence 
on PLTP-mediated size changes ( 63 ). The PLTP-mediated 
processes facilitate the transfer of surface remnants from 
lipolyzed triglyceride-rich lipoproteins to nascent HDL 
particles. 
 LCAT activation is infl uenced by the size of spherical 
HDL particles ( 64, 65 ). When the diameter of HDL parti-
cles increases the activity of LCAT enzyme is higher. Thus, 
we propose that the diameter of HDL particles is smaller 
in low HDL-C than in high HDL-C subjects. This lower ac-
tivity could be somehow related to the conformation of 
apoA-I which could depend on the size and the lipid com-
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cells plays an essential role for the infl ammatory processes 
in the pathogenesis of atherosclerosis ( 72 ). Elevated levels 
of TNF-  and hs-CRP indicate a low-grade infl ammation 
that could cause several downstream effects, such as activa-
tion of sphingomyelinase activities, and affect endothelial 
cell function and development of atherosclerosis. Connec-
tion to sphingomyelin metabolism is important, and acti-
vation of acid sphingomyelinase has been extensively 
studied in the past decade. The enzyme is highly activated 
by TNF-  ( 73, 74 ) and might affect the lower SM content 
in HDL derived from low HDL subjects. This issue needs 
further studies, such as in vitro cell cultures with the iso-
lated HDL particles derived from low and high HDL cho-
lesterol subjects, to make further conclusions on the 
physiological performance of the particles. 
 The marked differences in HDL lipid profi les reported 
here were obtained from the extreme ends of HDL-C levels 
in a large population cohort. Because of the relatively small 
sample size, the comparison of low versus high HDL-C al-
lowed us to minimize the effect of confounding factors and 
to study major differences. This approach helped us to ex-
tract the key compositional and structural features of HDL 
particles in the context of HDL-cholesterol that should be 
investigated further. To eliminate the confounding effect of 
variation in the amount of apoA-I protein, the HDL parti-
cles were modeled based on the conservative assumption 
that the number of apoA-I molecules per particle is the 
same in the high and low HDL-C groups. One should thus 
keep in mind that our simulation model may not correctly 
represent the virtual structure of HDL, in which different 
numbers of apoA-I are present. However, given that the ob-
served increase of average apoA-I amount in high HDL-C 
subjects would only decrease the relative amount of triacyl-
glycerols in high HDL-C subjects, the lipid spatial distribu-
tion differences between the high and low HDL-C subjects 
are likely even bigger than estimated by our simulations. 
 CONCLUSION 
 We detected many important lipid composition changes 
in subjects with high and low HDL-C. Elevated sphingomy-
elin in high HDL-C subjects confi rms and provides addi-
tional evidence for the anti-infl ammatory role of HDL. 
The lipid compositional changes also induced a surprising 
shift in the spatial distribution of triacylglycerols in sub-
jects with low levels of HDL-C. The prevalence of TGs on 
the surface of HDL particles in these subjects may affect 
the heteroexchange of core lipids by CETP as well as facili-
tate their modifi cation by hepatic lipase. Finally, our study 
suggests that combining molecular profi ling of lipopro-
teins with dynamic modeling of lipoprotein structure is a 
powerful new strategy that may help elucidate the com-
plexity of systemic lipid metabolism as well as facilitate ef-
forts to invent novel therapeutic strategies.  
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